CNR2 and breast carcinoma: Recent studies have in fact shown that, in breast cancer, CB2 forms heterodimers with epidermal growth factor receptor 2 (HER2), and treatment with THC exerts an anti-tumour effect in vitro and in vivo by disrupting CB2-HER2 dimers and inducing HER2 degradation [92,93].